Calliditas Therapeutics AB Sponsored ADR Operating Income 2020-2024 | CALT
Calliditas Therapeutics AB Sponsored ADR operating income from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Calliditas Therapeutics AB Sponsored ADR Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-35 |
| 2022 | $-42 |
| 2021 | $-61 |
| 2020 | $-41 |
| 2019 | $-3 |
| Calliditas Therapeutics AB Sponsored ADR Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-3 |
| 2024-03-31 | $-20 |
| 2023-12-31 | $4 |
| 2023-09-30 | $-15 |
| 2023-06-30 | $-7 |
| 2023-03-31 | $-17 |
| 2022-12-31 | $5 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-21 |
| 2022-03-31 | $-22 |
| 2021-12-31 | $-25 |
| 2021-09-30 | $1 |
| 2021-06-30 | $-19 |
| 2021-03-31 | $-18 |
| 2020-12-31 | $-15 |
| 2020-09-30 | $-12 |
| 2020-06-30 | $-7 |
| 2020-03-31 | $-7 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $9 |
| 2019-03-31 | $-5 |
